ProfileGDS4132 / 214822_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 45% 43% 48% 44% 48% 49% 49% 49% 46% 49% 47% 45% 53% 42% 48% 45% 46% 40% 41% 49% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101120.49345
GSM201543Muscle PCOS pioglitazone 121104.15543
GSM201544Muscle PCOS pioglitazone 161130.7748
GSM201545Muscle PCOS pioglitazone 201123.45944
GSM201829Muscle PCOS pioglitazone 231135.79848
GSM201830Muscle PCOS pioglitazon 251137.15249
GSM201831Muscle PCOS pioglitazone 271131.53549
GSM201832Muscle PCOS pioglitazone 31127.35549
GSM201833Muscle PCOS pioglitazone 41112.50746
GSM201834Muscle PCOS pioglitazone 81126.76849
GSM201835Muscle PCOS after pioglitazone 102111.97647
GSM201836Muscle PCOS after pioglitazone 122108.4745
GSM201837Muscle PCOS after pioglitazone 162124.79853
GSM201838Muscle PCOS after pioglitazone 20299.496342
GSM201839Muscle PCOS after pioglitazone 232119.8648
GSM201840Muscle PCOS after pioglitazone 252114.49345
GSM201841Muscle PCOS after pioglitazone 272105.02146
GSM201842Muscle PCOS after pioglitazone 3285.331540
GSM201843Muscle PCOS after pioglitazone 42103.71141
GSM201844Muscle PCOS after pioglitazone 82127.34749